The effect of rosiglitazone and pioglitazone on myocardial apoptosis

被引：0
|
作者：
Erkan, A. F. [1 ]
Bagriacik, U. [2 ]
Karasu, C. [1 ]
Yalcin, R. [1 ]
机构：
[1] Ufuk Univ, Ankara, Turkey
[2] Gazi Univ, Ankara, Turkey
来源：
EUROPEAN HEART JOURNAL | 2007年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：358 / 359
页数：2
相关论文
共 50 条
  • [21] Using thiazolidinediones: Rosiglitazone and pioglitazone in clinical practice
    Peters, AL
    AMERICAN JOURNAL OF MANAGED CARE, 2001, 7 (03): : S87 - S95
  • [22] Rosiglitazone, but Not Pioglitazone, Improves Myocardial Systolic Function in Type 2 Diabetic Patients: A Tissue Doppler Study
    Pala, Selcuk
    Esen, Oezlem
    Akcakoyun, Mustafa
    Kahveci, Goekhan
    Kargin, Ramazan
    Tigen, Kuersat
    Karaahmet, Tansu
    Acar, Goeksel
    Esen, Ali Metin
    Kirma, Cevat
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2010, 27 (05): : 512 - 518
  • [23] The effect of rosiglitazone and pioglitazone on VLDL apolipoprotein B metabolism in patients with type 2 diabetes
    Brackenridge, AL
    Jackson, N
    Shojaee-Moradie, F
    Umpleby, AM
    Russell-Jones, D
    DIABETES, 2005, 54 : A234 - A234
  • [24] No significant effect of SLCO1B1 polymorphism on the pharmacokinetics of rosiglitazone and pioglitazone
    Kalliokoski, Annikka
    Neuvonen, Mikko
    Neuvonen, Pertti J.
    Niemi, Mikko
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 65 (01) : 78 - 86
  • [25] Effect of diabetes and rosiglitazone on myocardial blood flow.
    Reaven, R
    Chen, Q
    Domb, A
    Gerkin, R
    Plummer, H
    Lawson, M
    DIABETOLOGIA, 2001, 44 : A57 - A57
  • [26] Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or Pioglitazone
    Graham, David J.
    Ouellet-Hellstrom, Rita
    MaCurdy, Thomas E.
    Ali, Farzana
    Sholley, Christopher
    Worrall, Christopher
    Kelman, Jeffrey A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (04): : 411 - 418
  • [27] Case series of liver failure associated with rosiglitazone and pioglitazone
    Floyd, James S.
    Barbehenn, Elizabeth
    Lurie, Peter
    Wolfe, Sidney M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 (12) : 1238 - 1243
  • [28] Rosiglitazone vs. Pioglitazone and Acute Myocardial Infarction: Systematic Review and Meta-Analysis of Observational Studies
    Pladevall, Manel
    Lorenzo, Cristina Varas
    Margulis, Andrea
    Riera-Guardia, Nuria
    Calingaert, Brian
    Romio, Silvana
    Sturkenboom, Miriam C. J. M.
    Perez-Gutthann, Susana
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 181 - 182
  • [29] Pioglitazone: better cardiac safety profile than rosiglitazone
    Reactions Weekly, 2009, 1267 (1) : 4 - 4
  • [30] Adverse Cardiovascular Events during Treatment with Pioglitazone and Rosiglitazone
    Juurlink, David N.
    Gomes, Tara
    Lipscombe, Lorraine L.
    Austin, Peter C.
    Hux, Jan E.
    Mamdani, Muhammad M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S194 - S194
12345